The first workshop in the business meeting reviewed the current state of ACTA, and where it should head. Participants received a background document on ACTA's Progress and Plans before the summit. The purpose of this workshop was to have an open discussion about ACTA and how it can help clinical trials. Participants asked multiple questions to clarify certain aspects of ACTA’s progress and plans document.
